fbpx
    • ASH
    • Multiple Myeloma News
    • Dec 05, 2018

    ASH 2018: Top 5 Abstracts from 7 Myeloma Specialists!

Mike ThompsonMichael Thompson, MD, PhD, at the Vince Lombardi  Cancer Clinic in Milwaukee, WI is board certified in hematology and oncology. He is an active clinical researcher whose interests include hematologic or blood cancers (lymphoma, myeloma, leukemia and myelodysplastic syndrome).  When my web site myelomasurvival.com was started in 2012, one of the first patients who called to find a myeloma specialist was a 28 year old man, who had recently got married, had no insurance, and felt doomed.  I had called a number of doctors in Wisconsin to find out if they could help.  Up until that point this young man had no future, and found no help available.  I talked with Dr. Thompson and he championed this young families cause until he was covered for all cost associated with his care.  Dr. Thompson saved his life and the future with his family.  Mike is not only an excellent myeloma specialist, but an outstanding humanitarian.

In addition, Dr. Thompson is the Myeloma Twitter King with over 17,000 followers.  In contrast Dr. Vincent Rajkumar of Mayo Clinic has 9300, and Brian Durie, Chairman of the International Myeloma Foundation has 2300.  So if you want to get the myeloma word out, Who You Gonna Call? Dr. Thompson.
 
I asked Dr. Thompson’s for his Top 5 2018 myeloma abstracts, but as always he went the extra mile and summarized all of the top 5 abstracts available. This is one of the most exceptional myeloma specialist group I know of.  Thank You Dr. Thompson, you do great work!  
 

#ASH18 Myeloma Top 5 Abstract Picks

 

 Abstracts

Costa

Fonseca

Hari

Landgren

Rajkumar

Thompson

Usmani

LBA-2 – Facon D-Rd vs Rd NDMM – MAIA

 

X

 

 

 

X

X

121 Gay – KRd or KCd pre ASCT or KRD12

X

X

X

 

 

X

X

190 Samur MM Genomics

 

 

 

 

 

X

 

280 Pawlyn Myeloma XI

 

 

 

 

+1

 

 

301 Dimopoulos -Tourmaline MM3 Ixa maint

X

X

 

 

X

 

 

303 Costa – Kd-VEN RRMM

 

 

X

 

 

X

X

305 Larocca – Rd x9 -> R

 

 

 

 

X

 

 

405 Barwick Ig L IMiD res

 

 

 

 

X

 

 

589 Smith GPRC5D CART

 

 

 

X

 

 

 

598 Chari STORM Selinixor

 

X

X

 

 

X

 

949 Sperling – Thalidomide res

 

 

 

 

X

 

 

955 Zhao – LCAR B38M CART

X

 

 

X

 

 

X

957 Mailankody – JCARH125 CART

 

 

 

X

 

 

 

1009 Shi – Tandem ASCT & CART

 

 

X

 

 

 

 

1010 Topp AMG 420 anti-BCMA BiTE

X

X

X

X

X

 

X

1994 Landgren SMM Dara

 

 

 

X

 

 

 

2015 Cornell Tx after CD38 refractory

+1

 

 

 

 

 

 

3233 Ghandi CD38 refractory hx

X

 

 

 

 

 

 

3281 Landgren NDMM DKRd MRD

 

 

 

X

 

 

 

3282 Kaufman RVD t(11;14) outcomes

 

 

 

 

 

+1

 

            Green = CART or BiTE

            Purple = CD38 / Dara

            Red = Venetoclax or t(11;14)

About Author

Gary Petersen

Gary is a myeloma survivor and patient advocate. His work centers around helping patients live longer by helping them to find facilities who are beating the average survival statistics. You can find Gary's site at www.myelomasurvival.com and follow him on Twitter at @grpetersen1

MYELOMA CROWD RESEARCH INITIATIVE
$99,715 of $500,000 Raised
BRINGING THE RIGHT TREATMENT TO THE PATIENT AT THE RIGHT TIME
Please Help Us Reach Our Goal
AmazonSmile

Get Started Today.

Find a Clinical Trial that's Right for You

Go

Thanks to our site sponsors: